|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:1073-1079
© 2006 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease |
a The Inova Heart and Vascular Institute, Falls Church, Va
b The Hadassah Hebrew University Medical Center, Jerusalem, Israel
Received for publication June 14, 2005; revisions received December 20, 2005; accepted for publication December 27, 2005. * Address for reprints: Niv Ad, MD, Director of Cardiac Surgery Research, Division of Cardiac Surgery, Inova Heart and Vascular Institute, 3300 Gallows Road, Falls Church, VA 22042 (Email: niv.ad{at}inova.com).
OBJECTIVES: The most important predictors for failure of the maze procedure are long standing atrial fibrillation (AF), rheumatic heart disease (RHD), and enlarged atria. It is well documented, however, that some patients have recurrence of atrial arrhythmia only late in follow-up. The aims of this study are to assess the effectiveness of the maze procedure and late cardioversion (pharmacologic or electrical) in patients wtih an increased risk for procedure failure.
PATIENTS AND METHODS: Fifty-five patients with AF, enlarged left atrium (>5 cm), and/or RHD were enrolled in the study. Cryosurgery was performed on all patients and was combined with bipolar radiofrequency in the last four patients. The lesion pattern resembles the maze procedure. A follow-up was completed on all patients (24.5 ± 9.6 months with a range of 3-39 months).
RESULTS: The operative mortality was 3.7% (2 patients), both deaths unrelated to the maze procedure. Ninety-eight percent of patients were free of AF upon discharge, with an 11% incidence of early pacemaker implantation. In the first three months postoperatively, 53% of the patients experienced intermittent atrial arrhythmia. Four patients were recorded with permanent AF in late follow-up. The only predictor for late AF (>3 months of follow-up) was perioperative AF. Atrial size, RHD, and AF duration did not predict late failure.
CONCLUSIONS: The maze procedure can be applied with high success rate in patients with RHD, enlarged atria, and long-standing AF. In our experience many of the late recurrences were recorded late in the follow-up and were treated successfully with antiarrhythmic drugs and/or cardioversion. Therefore a close follow-up is required to enhance the success rate of the procedure.
This article has been cited by other articles:
![]() |
Y. Louagie, M. Buche, P. Eucher, J.-C. Schoevaerdts, M. Gerard, J. Jamart, and D. Blommaert Improved patient survival with concomitant Cox Maze III procedure compared with heart surgery alone. Ann. Thorac. Surg., February 1, 2009; 87(2): 440 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Ghavidel, H. Javadpour, M. Shafiee, M.-B. Tabatabaie, K. Raiesi, and S. Hosseini Cryoablation for surgical treatment of chronic atrial fibrillation combined with mitral valve surgery: a clinical observation Eur. J. Cardiothorac. Surg., June 1, 2008; 33(6): 1043 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-B. Kim Reply to Villa et al. Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 399 - 399. [Full Text] [PDF] |
||||
![]() |
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace, June 1, 2007; 9(6): 335 - 379. [Full Text] [PDF] |
||||
![]() |
K. C. Kim, K. R. Cho, Y.-J. Kim, D.-W. Sohn, and K.-B. Kim Long-term results of the Cox-Maze III procedure for persistent atrial fibrillation associated with rheumatic mitral valve disease: 10-year experience Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 261 - 266. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |